1.Reintam A, Parm P, Kitus R, Kern H, Starkopf J: Gastrointestinal symptoms in intensive care patients. Acta Anaesthesiol Scand 2009, 53(3):318–324.
2.Yu Y, Yang Y, Bian Y, Li Y, Liu L, Zhang H, Xie K, Wang G, Yu Y: Hydrogen Gas Protects Against Intestinal Injury in Wild Type But Not NRF2 Knockout Mice With Severe Sepsis by Regulating HO–1 and HMGB1 Release. Shock 2017, 48(3):364–370.
3.Taylor RW: Gut Motility Issues in Critical Illness. Crit Care Clin 2016, 32(2):191–201.
4.Klingensmith NJ, Coopersmith CM: The Gut as the Motor of Multiple Organ Dysfunction in Critical Illness. Crit Care Clin 2016, 32(2):203–212.
5.Kelly DA: Intestinal failure-associated liver disease: what do we know today? Gastroenterology 2006, 130(2 Suppl 1):S70–77.
6.Reintam Blaser A, Malbrain ML, Starkopf J, Fruhwald S, Jakob SM, De Waele J, Braun JP, Poeze M, Spies C: Gastrointestinal function in intensive care patients: terminology, definitions and management. Recommendations of the ESICM Working Group on Abdominal Problems. Intensive Care Med 2012, 38(3):384–394.
7.Cicione C, Degirolamo C, Moschetta A: Emerging role of fibroblast growth factors 15/19 and 21 as metabolic integrators in the liver. Hepatology 2012, 56(6):2404–2411.
8.Iwamoto J, Saito Y, Honda A, Miyazaki T, Ikegami T, Matsuzaki Y: Bile acid malabsorption deactivates pregnane X receptor in patients with Crohn’s disease. Inflamm Bowel Dis 2013, 19(6):1278–1284.
9.Nolan JD, Johnston IM, Pattni SS, Dew T, Orchard TR, Walters JR: Diarrhea in Crohn’s disease: investigating the role of the ileal hormone fibroblast growth factor 19. J Crohns Colitis 2015, 9(2):125–131.
10.You M, Zhou Z, Daniels M, Jogasuria A: Endocrine Adiponectin-FGF15/19 Axis in Ethanol-Induced Inflammation and Alcoholic Liver Injury. Gene Expr 2018, 18(2):103–113.
11.Luo J, Ko B, Elliott M, Zhou M, Lindhout DA, Phung V, To C, Learned RM, Tian H, DePaoli AM et al: A nontumorigenic variant of FGF19 treats cholestatic liver diseases. Sci Transl Med 2014, 6(247):247ra100.
12.Goldstein B, Giroir B, Randolph A, International Consensus Conference on Pediatric S: International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005, 6(1):2–8.
13.Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R et al: Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013, 41(2):580–637.
14.Sutherland SM, Byrnes JJ, Kothari M, Longhurst CA, Dutta S, Garcia P, Goldstein SL: AKI in hospitalized children: comparing the pRIFLE, AKIN, and KDIGO definitions. Clin J Am Soc Nephrol 2015, 10(4):554–561.
15.Mutlu GM, Mutlu EA, Factor P: GI complications in patients receiving mechanical ventilation. Chest 2001, 119(4):1222–1241.
16.Montejo JC: Enteral nutrition-related gastrointestinal complications in critically ill patients: a multicenter study. The Nutritional and Metabolic Working Group of the Spanish Society of Intensive Care Medicine and Coronary Units. Crit Care Med 1999, 27(8):1447–1453.
17.Reintam A, Parm P, Kitus R, Starkopf J, Kern H: Gastrointestinal failure score in critically ill patients: a prospective observational study. Crit Care 2008, 12(4):R90.
18.Lam SW, Nguyen NQ, Ching K, Chapman M, Fraser RJ, Holloway RH: Gastric feed intolerance is not increased in critically ill patients with type II diabetes mellitus. Intensive Care Med 2007, 33(10):1740–1745.
19.Lebuffe G, Vallet B, Takala J, Hartstein G, Lamy M, Mythen M, Bakker J, Bennett D, Boyd O, Webb A: A european, multicenter, observational study to assess the value of gastric-to-end tidal PCO2 difference in predicting postoperative complications. Anesth Analg 2004, 99(1):166–172.
20.Reintam Blaser A, Poeze M, Malbrain ML, Bjorck M, Oudemans-van Straaten HM, Starkopf J, Gastro-Intestinal Failure Trial G: Gastrointestinal symptoms during the first week of intensive care are associated with poor outcome: a prospective multicentre study. Intensive Care Med 2013, 39(5):899–909.
21.Gao Y, Yu KJ, Kang K, Liu HT, Zhang X, Huang R, Qu JD, Wang SC, Liu RJ, Liu YS et al: Procalcitionin as a diagnostic marker to distinguish upper and lower gastrointestinal perforation. World J Gastroenterol 2017, 23(24):4422–4427.
22.van Nieuwkoop C, Bonten TN, van’t Wout JW, Kuijper EJ, Groeneveld GH, Becker MJ, Koster T, Wattel-Louis GH, Delfos NM, Ablij HC et al: Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study. Crit Care 2010, 14(6):R206.
23.Jiang L, Feng B, Gao D, Zhang Y: Plasma concentrations of copeptin, C-reactive protein and procalcitonin are positively correlated with APACHE II scores in patients with sepsis. J Int Med Res 2015, 43(2):188–195.
24.Liu D, Su LX, Guan W, Xiao K, Xie LX: Prognostic value of procalcitonin in pneumonia: A systematic review and meta-analysis. Respirology 2016, 21(2):280–288.
25.Jain S, Sinha S, Sharma SK, Samantaray JC, Aggrawal P, Vikram NK, Biswas A, Sood S, Goel M, Das M et al: Procalcitonin as a prognostic marker for sepsis: a prospective observational study. BMC Res Notes 2014, 7:458.
26.Coufal S, Kokesova A, Tlaskalova-Hogenova H, Snajdauf J, Rygl M, Kverka M: Urinary Intestinal Fatty Acid-Binding Protein Can Distinguish Necrotizing Enterocolitis from Sepsis in Early Stage of the Disease. J Immunol Res 2016, 2016:5727312.